Viewing Study NCT06678620


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2025-12-26 @ 3:28 AM
Study NCT ID: NCT06678620
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-17
First Post: 2024-11-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine
Sponsor: Shanghai Reinovax Biologics Co.,LTD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module